SINGAPORE (Reuters) – Singapore is expecting shipment delays of Pfizer-BioNTech vaccines due to upgrades in Pfizer’s manufacturing plant, its health ministry said on Friday.
The ministry said the city-state had so far administered first doses of the vaccine to more than 60,000 people and would monitor supplies closely to ensure all Singaporeans and long-term residents are inoculated by the third quarter of 2021.
(Reporting by Chen Lin; Editing by Martin Petty)
